NFKB1 and Hepatic fibrosis: These results suggest that inhibition of the TLR4-MyD88-NFκB-mediated inflammatory response can down-regulate the expression of TLR4 mRNA and protein, thereby improving hepatic fibrosis (91) (Table 1).